These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 11251979

  • 1. Lectin-deficient TNF mutants display comparable anti-tumour but reduced pro-metastatic potential as compared to the wild-type molecule.
    Lucas R, Montesano R, Pepper MS, Hafner M, Sablon E, Dunant Y, Grau GE, De Baetselier P, Männel D, Fransen L.
    Int J Cancer; 2001 Feb 15; 91(4):543-9. PubMed ID: 11251979
    [Abstract] [Full Text] [Related]

  • 2. Generation of a mouse tumor necrosis factor mutant with antiperitonitis and desensitization activities comparable to those of the wild type but with reduced systemic toxicity.
    Lucas R, Echtenacher B, Sablon E, Juillard P, Magez S, Lou J, Donati Y, Bosman F, Van de Voorde A, Fransen L, Männel DN, Grau GE, de Baetselier P.
    Infect Immun; 1997 Jun 15; 65(6):2006-10. PubMed ID: 9169725
    [Abstract] [Full Text] [Related]

  • 3. Optimal site-specific PEGylation of mutant TNF-alpha improves its antitumor potency.
    Yoshioka Y, Tsutsumi Y, Ikemizu S, Yamamoto Y, Shibata H, Nishibata T, Mukai Y, Okamoto T, Taniai M, Kawamura M, Abe Y, Nakagawa S, Nagata S, Yamagata Y, Mayumi T.
    Biochem Biophys Res Commun; 2004 Mar 19; 315(4):808-14. PubMed ID: 14985084
    [Abstract] [Full Text] [Related]

  • 4. Anti-tumor action of tumor necrosis factor against Bomirski Ab melanoma in hamsters.
    Koszałka P, Szmit E, Myśliwski A, Bigda J.
    Arch Immunol Ther Exp (Warsz); 2007 Mar 19; 55(4):267-79. PubMed ID: 17659374
    [Abstract] [Full Text] [Related]

  • 5. Functionalization of tumor necrosis factor-alpha using phage display technique and PEGylation improves its antitumor therapeutic window.
    Shibata H, Yoshioka Y, Ikemizu S, Kobayashi K, Yamamoto Y, Mukai Y, Okamoto T, Taniai M, Kawamura M, Abe Y, Nakagawa S, Hayakawa T, Nagata S, Yamagata Y, Mayumi T, Kamada H, Tsutsumi Y.
    Clin Cancer Res; 2004 Dec 15; 10(24):8293-300. PubMed ID: 15623605
    [Abstract] [Full Text] [Related]

  • 6. A YIGSR-containing novel mutein without the detrimental effect of human TNF-alpha of enhancing experimental pulmonary metastasis.
    Miyata K, Kato M, Shikama H, Nishimura K, Sakae N, Kawagoe K, Nishikawa T, Kuroda K, Yamaguchi K, Aoyama Y.
    Clin Exp Metastasis; 1992 Jul 15; 10(4):267-72. PubMed ID: 1617834
    [Abstract] [Full Text] [Related]

  • 7. Antitumor activity of a novel chimera tumor necrosis factor (TNF-STH) constructed by connecting rTNF-S with thymosin beta 4 against murine syngeneic tumors.
    Noguchi K, Inagawa H, Tsuji Y, Morikawa A, Mizuno D, Soma G.
    J Immunother (1991); 1991 Apr 15; 10(2):105-11. PubMed ID: 2043590
    [Abstract] [Full Text] [Related]

  • 8. Enhancement of experimental metastasis by tumor necrosis factor.
    Orosz P, Echtenacher B, Falk W, Rüschoff J, Weber D, Männel DN.
    J Exp Med; 1993 May 01; 177(5):1391-8. PubMed ID: 8478614
    [Abstract] [Full Text] [Related]

  • 9. Changes in endogenous cytokines, adhesion molecules and platelets during cytokine-induced tumour necrosis.
    de Kossodo S, Moore R, Gschmeissner S, East N, Upton C, Balkwill FR.
    Br J Cancer; 1995 Nov 01; 72(5):1165-72. PubMed ID: 7577463
    [Abstract] [Full Text] [Related]

  • 10. Tumour immunotherapy using an adenoviral vector expressing a membrane-bound mutant of murine TNF alpha.
    Marr RA, Addison CL, Snider D, Muller WJ, Gauldie J, Graham FL.
    Gene Ther; 1997 Nov 01; 4(11):1181-8. PubMed ID: 9425441
    [Abstract] [Full Text] [Related]

  • 11. Tumor necrosis factor induces tumor necrosis via tumor necrosis factor receptor type 1-expressing endothelial cells of the tumor vasculature.
    Stoelcker B, Ruhland B, Hehlgans T, Bluethmann H, Luther T, Männel DN.
    Am J Pathol; 2000 Apr 01; 156(4):1171-6. PubMed ID: 10751341
    [Abstract] [Full Text] [Related]

  • 12. Thrombomodulin is a determinant of metastasis through a mechanism linked to the thrombin binding domain but not the lectin-like domain.
    Horowitz NA, Blevins EA, Miller WM, Perry AR, Talmage KE, Mullins ES, Flick MJ, Queiroz KC, Shi K, Spek CA, Conway EM, Monia BP, Weiler H, Degen JL, Palumbo JS.
    Blood; 2011 Sep 08; 118(10):2889-95. PubMed ID: 21788337
    [Abstract] [Full Text] [Related]

  • 13. Efficiency of recombinant human TNF in human cancer therapy.
    Lejeune FJ, Liénard D, Matter M, Rüegg C.
    Cancer Immun; 2006 Mar 22; 6():6. PubMed ID: 16551058
    [Abstract] [Full Text] [Related]

  • 14. Enhancement of tumor necrosis factor alpha antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13).
    Curnis F, Sacchi A, Borgna L, Magni F, Gasparri A, Corti A.
    Nat Biotechnol; 2000 Nov 22; 18(11):1185-90. PubMed ID: 11062439
    [Abstract] [Full Text] [Related]

  • 15. Self-targeting of TNF-releasing cancer cells in preclinical models of primary and metastatic tumors.
    Dondossola E, Dobroff AS, Marchiò S, Cardó-Vila M, Hosoya H, Libutti SK, Corti A, Sidman RL, Arap W, Pasqualini R.
    Proc Natl Acad Sci U S A; 2016 Feb 23; 113(8):2223-8. PubMed ID: 26858439
    [Abstract] [Full Text] [Related]

  • 16. Preferential activity of wild-type and mutant tumor necrosis factor-alpha against tumor-derived endothelial-like cells.
    Kuroda K, Miyata K, Tsutsumi Y, Tsunoda S, Nishimura K, Mitsuishi Y, Nakagawa S, Mayumi T.
    Jpn J Cancer Res; 2000 Jan 23; 91(1):59-67. PubMed ID: 10744045
    [Abstract] [Full Text] [Related]

  • 17. [Modifying effects of recombinant tumor necrosis factor on the metastatic potential of tumor cells].
    Kudriavets IuI.
    Eksp Onkol; 1990 Jan 23; 12(1):43-7. PubMed ID: 2298142
    [Abstract] [Full Text] [Related]

  • 18. Involvement of very late activation antigen 4 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) in tumor necrosis factor alpha enhancement of experimental metastasis.
    Okahara H, Yagita H, Miyake K, Okumura K.
    Cancer Res; 1994 Jun 15; 54(12):3233-6. PubMed ID: 7515767
    [Abstract] [Full Text] [Related]

  • 19. A novel recombinant tumor necrosis factor-alpha mutant with increased anti-tumor activity and lower toxicity.
    Nakamura S, Kato A, Masegi T, Fukuoka M, Kitai K, Ogawa H, Ichikawa Y, Maeda M, Watanabe N, Kohgo Y.
    Int J Cancer; 1991 Jul 09; 48(5):744-8. PubMed ID: 1649139
    [Abstract] [Full Text] [Related]

  • 20. Anti-angiogenic cues from vascular basement membrane collagen.
    Colorado PC, Torre A, Kamphaus G, Maeshima Y, Hopfer H, Takahashi K, Volk R, Zamborsky ED, Herman S, Sarkar PK, Ericksen MB, Dhanabal M, Simons M, Post M, Kufe DW, Weichselbaum RR, Sukhatme VP, Kalluri R.
    Cancer Res; 2000 May 01; 60(9):2520-6. PubMed ID: 10811134
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.